Would you like to know if you’ve had COVID-19?

The BioDiagnostics BioCard™ was developed in direct response to the COVID-19 pandemic, with research beginning in February 2020 in the UK. The BioCard™ utilises the company’s 40 years’ experience in antibody testing and its extensive in vitro diagnostics expertise. The BioCard™ is CE marked and available for delivery throughout the UK and Europe immediately, and the USA imminently.

Physical adaptations from the established QuickCard™ technology, combined with specific changes to the Biochemistry of the device, have resulted in a robust, accurate and ultra-rapid IgG antibody test indicative of a COVID-19 specific immune response.

A positive result demonstrates the presence of specific antibodies to protect against COVID-19, almost certainly inferring past infection.


Natures Vaccine?

These specific antibodies are the same ones it is anticipated will be elicited by vaccines currently in development, which aim which provide immunity to COVID-19 infections. If you have a positive result, it very strongly suggests your body has already made them, naturally.


I found Bio-diagnostics more than helpful, replacing all our allergens in a very quick and efficient way, reducing the complexity of ordering and providing an excellent service to us.

Melanie Paddon, OPD, Circle, Bath.

The company and individual staff are very attentive and efficient at responding to our needs. I would not hesitate in recommending Bio-diagnostics to provide a solution for any potential customers. Thanks Bio-diagnostics.

Martin Davies, Manager Immunology, Prince Philip Hospital, Hywel Dda University Health Board

Brilliant support from very knowledgeable and friendly team. Nothing is ever too much trouble - Thank you!

Pearl Huey, BCULHB Service Manager for Cellular Pathology.

We have been customers of Bio-Diagnostics for over 10 years and have always found their products to be of a high and consistent quality, and customer service to be excellent.